A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

News

News

All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities. 

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

25 Jan 2018

Live WEF discussion with Bill Gates & Jayasree Iyer at 1pm CET: “New Era For Global Health”

Jayasree K. Iyer joins Bill Gates and others to discuss how new leadership, policy and business models are rewriting the global health playbook.

23 Jan 2018

The first Benchmark launches at the WEF in Davos

At 14:00 CET on Tuesday 23 January, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, will launch the first Antimicrobial Res...

23 Jan 2018

Now published: first independent comparison of pharma companies’ efforts to address drug-resistant infections

Amsterdam, Davos, 23 January 2018 – The first independent analysis of pharmaceutical industry efforts to tackle drug resistance, published today, find...

19 Jan 2018

Watch the live launch of the Antimicrobial Resistance Benchmark – on Tues 23 Jan

Starting at 14:00 CET on Tuesday 23 January, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, will present the results of th...

12 Jan 2018

A look back at a year of vaccine announcements

Since we published the Access to Vaccines Index in March 2017, vaccine companies have reported a series of positive developments in their efforts to a...

04 Jan 2018

Why the Index is now researching access to cancer care

For the first time, in 2018, the Access to Medicine Index is looking at cancer. Writing in Cancer Control 2017, we describe why and how it has been br...

21 Dec 2017

First Antimicrobial Resistance Benchmark will be published in January at the WEF, Davos

The Foundation will launch the first Antimicrobial Resistance Benchmark at the WEF Annual Meeting in Davos in January 2018. It will be the first indep...

13 Dec 2017

How the Access to Medicine Foundation is raising the bar for Index making

The Foundation’s sixth Index cycle is proving to be its most innovative – this article provides a brief rundown of the groundwork laid for the next Ac...

30 Nov 2017

World AIDS Day: Foundation and CHAI publish paper on licensing ARVs to improve access

Approximately 20.9 million people living with HIV/AIDS now have access to treatment – out of an estimated 36.7 million people worldwide living with th...

12 Oct 2017

The Lancet publishes commentary on AMR Benchmark

A new Commentary published today in The Lancet discusses the potential of the new Antimicrobial Resistance Benchmark to stimulate pharmaceutical compa...

05 Oct 2017

Latest framework for action by pharmaceutical companies on access to medicine

The world’s leading pharmaceutical companies have the power and the products to improve access to medicine. To help guide their actions, the Access to...

24 Aug 2017

Now online: first independent framework for assessing pharma company action on AMR

Today, the Access to Medicine Foundation publishes the methodology for its 2018 Antimicrobial Resistance Benchmark. It is the first independently deve...

09 Aug 2017

Online soon: new methodology for Antimicrobial Resistance Benchmark

The Access to Medicine Foundation will shortly publish the methodology for a new tool – an Antimicrobial Resistance Benchmark that will evaluate how p...

22 May 2017

New study finds wide variety in pharma companies’ cancer access programmes

Today, the Access to Medicine Foundation publishes the first analysis of pharmaceutical company actions to improve cancer care in the developing world...

21 Apr 2017

The Access to Medicine Foundation has moved to Amsterdam

The Access to Medicine Foundation has outgrown its former office in Haarlem and moved to a larger space in Amsterdam.

06 Mar 2017

New Access to Vaccines Index reveals first landscape of vaccine company actions to improve immunisation coverage

The 2017 Access to Vaccines Index reveals the first landscape of industry activity to improve immunisation coverage. It finds a high level of diversit...

Back to top |